All products / Usage / Recovery & Repair
TCI Blend 12mg Snap Pen
GH-pathway, metabolic & recovery research
Recovery & RepairSnap PenMuscle & PerformanceWeight & Metabolism
SKU: SP-TCI-12-1
$165$140Save $25 (−15%)
- Format
- Snap Pen
- Dosage
- 0.12mg combined per click
- Capacity
- 12 mg
Potential benefits
- GH-pathway research
- Recovery & adaptation research
- GH secretion research
- Body-composition research
- Multi-pathway GH design
TCI Blend is a synergistic peptide formulation combining Tesamorelin, CJC-1295 (No DAC), and Ipamorelin—three peptides that work together to support endogenous growth hormone signaling, metabolic balance, tissue maintenance, and recovery pathways. By integrating a long-acting GHRH analog (Tesamorelin) with a short-acting GHRH analog (CJC-1295 No DAC) and a selective ghrelin receptor agonist (Ipamorelin),
TCI Blend is designed to stimulate physiological, pulsatile GH release through multiple complementary mechanisms.
Peptide Composition
Tesamorelin — A stabilized Growth Hormone Releasing Hormone (GHRH) analog associated with endogenous GH stimulation and metabolic signalling.
CJC-1295 (No DAC) — A Growth Hormone Releasing Hormone (GHRH) analog that promotes pulsatile GH release.
Ipamorelin — A selective ghrelin receptor agonist that stimulates GH release without significantly affecting cortisol or prolactin. Combined peptide activity supports cellular recovery and metabolic adaptation.
TCI Blend is designed to stimulate physiological, pulsatile GH release through multiple complementary mechanisms.
Peptide Composition
Tesamorelin — A stabilized Growth Hormone Releasing Hormone (GHRH) analog associated with endogenous GH stimulation and metabolic signalling.
CJC-1295 (No DAC) — A Growth Hormone Releasing Hormone (GHRH) analog that promotes pulsatile GH release.
Ipamorelin — A selective ghrelin receptor agonist that stimulates GH release without significantly affecting cortisol or prolactin. Combined peptide activity supports cellular recovery and metabolic adaptation.
- Encourages natural GH and IGF-1 signaling.
- Studied in the context of recovery following physical stress or training.
- Encourages natural GH release and downstream IGF-1 activity.
- GH-mediated pathways are studied for their role in muscle and fat metabolism.
- Combines regenerative and endocrine pathways in one formulation.
References
- Tesamorelin as a GHRH analog
- Long-term effects on visceral fat and safety in extended treatment
- GH axis and GHRH mechanisms
- CJC-1295 (No DAC) peptide analogs & GH response
- Ghrelin receptor agonists and GH release
- Ipamorelin as a selective GH secretagogue: Ipamorelin as a selective GH secretagogue
| Molecular formula | C₂₂₁H₃₆₆N₇₂O₆₇/ C₁₅₂H₂₅₂N₄₄O₄₂ / C₃₈H₄₉N₉O₅ |
|---|---|
| CAS number | 218949-48-5 |
| Storage | Before reconstitution, store 6–50°C, refrigeration is not required. After reconstitution (mixing), keep refrigerated at 2–8°C at all times, use within 6 weeks. Do not freeze. Keep away from direct sunlight and heat. |
Synonyms: Tesamorelin, 218949-48-5, Egrifta, GrowthEgrifta, Hormone Releasing Hormone analog, GHRH (1–44) acetate, stabilized GHRH peptide CJC-1295 (No DAC), CJC 1295 No DAC, Modified GRF (1-29), Mod GRF 1-29, 863288-34-0, Growth Hormone Releasing Hormone analog, GHRH analog Ipamorelin, NNC 26-0161, 170851-70-4, Growth Hormone Secretagogue, Ghrelin receptor agonist,, GHS-R1a agonist
